Nanobiotix (NBTX) Total Debt (2018 - 2025)

Nanobiotix (NBTX) has 8 years of Total Debt data on file, last reported at $111.0 million in Q4 2025.

• In Q4 2025, Total Debt rose 103.99% year-over-year to $111.0 million; the TTM figure through Dec 2025 stood at $111.0 million (up 103.99% YoY), while the FY2025 annual figure was $107.7 million, up 95.47% from the prior year.
• Total Debt grew to $111.0 million in Q4 2025, from $54.4 million in the prior quarter.
• Across five years, Total Debt topped out at $111.0 million in Q4 2025 and bottomed at $32.7 million in Q4 2022.
• A 5-year average of $61.0 million and a median of $54.4 million in 2024 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt slumped 37.87% — and 2025, when it jumped 103.99%.
• Year by year, Total Debt stood at $52.6 million in 2021, then sank by 37.87% to $32.7 million in 2022, then soared by 66.33% to $54.4 million in 2023, then fell by 0.02% to $54.4 million in 2024, then jumped by 103.99% to $111.0 million in 2025.
• The last three Total Debt figures came in at $111.0 million (Q4 2025), $54.4 million (Q4 2024), and $54.4 million (Q4 2023), per Business Quant data.

Peer Comparison